PUBLIC CONTRACT · 2020
4180457/2020-aq. Central N175 - Nivolumab 100MG (10MG/ml fr 10ML) sol inj e nivolumab 40MG
- Contract value
- €55,064.30
- Signed on
- 13 October 2020
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7266716PUBLISHED SUBJECT
4180457/2020-AQ. CENTRAL N175 - NIVOLUMAB 100MG (10MG/ML FR 10ML) SOL INJ E NIVOLUMAB 40MG
Parties involved
- Awardee
- - - BRISTOL-MYERS SQUIB FARMAC PORTUGUESA SA
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - BRISTOL-MYERS SQUIB FARMAC PORTUGUESA SA
Values and timeline
- Contract price
- €55,064.30
- Procedure base price
- €55,064.30
- Total effective price
- €55,064.30
- Publication date
- 9 November 2020
- Award date
- 13 October 2020
- Signing date
- 13 October 2020
- Performance period
- 2 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2018/64 - Medicamentos Diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4976262
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.